Featured news in The Life Sciences Report



Athersys Inc. (ATHX:NASDAQ)
Athersys Announces Financial Results for Fourth Quarter and Full Year 2018 (3/14/2019)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results (3/15/2019)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results (3/14/2019)

view
 

Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million (3/14/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why (3/14/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up (3/14/2019)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time (3/13/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma (3/13/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Top Ranked Value Stocks to Buy for March 14th (3/14/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News (3/13/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Advancing Clinical Trials For Leukemia Patients Is Helping Improve Survival Rate (3/14/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS (3/14/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Zacks.com featured expert Kevin Matras highlights: Sallie Mae, United Continental, Celgene and Ligand Pharmaceuticals (3/13/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Regeneron/Sanofi's Dupixent Gets FDA Nod for Label Expansion (3/12/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
CELG vs. VRTX: Which Stock Is the Better Value Option? (3/13/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Features at Upcoming U.S. Investor Conferences (3/13/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
VIDEO: BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) (3/13/2019)

view